Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans

AIDS

Volumn 26, Issue 2, 2012, Pages 229-234

  Nurutdinova, Diana ^a,b   Chrusciel, Timothy ^a,b   Zeringue, Angelique ^a,b   Scherrer, Jeffrey F ^a,b   Al Aly, Ziyad ^a   McDonald, Jay R ^a,b   Overton, Edgar T ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; mental health; mortality; outcomes; veterans

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOPHRENIA; SUBSTANCE ABUSE; SURVIVAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COMORBIDITY; DEPRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS; UNITED STATES; VETERANS; VETERANS HEALTH;

EID: 84055173209     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834e1404     Document Type: Article

References (41)

1. Lyketsos CG, Hutton H, Fishman M, Schwartz J, Treisman GJ. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS 1996; 10:1033-1039.
2. Fuller BE, Loftis JM, Rodriguez VL, McQuesten MJ, Hauser P. Psychiatric and substance use disorders comorbidities in veterans with hepatitis C virus and HIV coinfection. Curr Opin Psychiatry 2009; 22:401-408.
3. Backus LI, Boothroyd D, Deyton LR. HIV, hepatitis C and HIV/ hepatitis C virus co-infection in vulnerable populations. AIDS 2005; 19 (Suppl 3):S13-S19.
4. Rothbard AB, Metraux S, Blank MB. Cost of care for medicaid recipients with serious mental illness and HIV infection or AIDS. Psychiatric Serv 2003; 54:1240-1246.
5. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999; 13:1763-1769.
6. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA 2001; 285:1466-1474.
7. Mohl PC, Huang L, Bowden C, Fischbach M, Vogtsberger K, Talal N. Natural killer cell activity in major depression. Am J Psychiatry 1987; 144:1619a.
8. Farinpour R, Miller EN, Satz P, Selenes OA, Cohen BA, Becker JT, et al. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol 2003; 25:654-670.
9. Lyketsos CG, Hoover DR, Guccione M, Senterfitt W, Dew MA, Wesch JE, et al. Depressive symptoms as predictors of medical outcomes in HIV Infection. JAMA 1993; 270:2563-2567.
10. Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, et al. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry 1996; 153:1430-1437.
11. Lima VD, Geller J, Bangsberg DR, Patterson TL, Daniel M, Kerr T, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS 2007; 21:1175-1183.
12. Asch SM, Kilbourne AM, Gifford AL, Burnam AM, Turner B, Shapiro MF, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med 2003; 18:450-460.
13. Tempalski B, Cleland C, Pouget E, Chatterjee S, Friedman S. Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas.. Substance Abuse Treatment Prevent Policy 2010; 5:23.
14. Conover C, Weaver M, Arno P, Ang A, Ettner S. Insurance coverage among people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders. J Healthcare Poor Underserved 2010; 21:1006-1030.
15. Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://www.aidsinfo.nih.gov/. [Accessed 6 June 2011]
16. Backus L, Mole L, Chang S, Deyton L. The immunology case registry. J Clin Epidemiol 2001; 54:S12-S15.
17. Rabeneck L, Menke T, Simberkoff MS, Hartigan PM, Dickinson GM, Jensen PC, et al. Using the national registry of HIVinfected veterans in research: lessons for the development of disease registries. J Clin Epidemiol 2001; 54:1195-1203.
18. Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res 2003; 38:1103-1120.
19. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154:854-864.
20. Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O'Connor PJ. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual 2006; 21:238-245.
21. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007; 10:3-12.
22. Centers for Disease Control and Prevention. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years: United States, 2008. Morb Mortal Wkly Rep 2008; 57:9
23. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58:721-728.
24. Mkanta WN, Mejia MC, Duncan RP. Race, outpatient mental health service use, and survival after an AIDS diagnosis in the highly active antiretroviral therapy era. AIDS Patient Care STDS 2010; 24:31-37.
25. Tabbane K, Joober R, Spadone C, Poirier M, Olie' J. Mortality and cause of death in schizophrenia. Review of the literature [Abstract]. Encephale 1993; 19:23-28.
26. Chang CK, Hayes R, Broadbent M, Fernandes A, Lee W, Hotopf M, et al. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 2010; 10:77.
27. Chwastiak LA, Rosenheck RA, Desai R, Kazis LE. Association of psychiatric illness and all-cause mortality in the National Department of Veterans Affairs Healthcare System. Psychosom Med 2010; 72:817-822.
28. Vinogradova Y, Coupland C, Hippisley-Cox J, Whyte S, Penny C. Effects of severe mental illness on survival of people with diabetes. Br J Psychiatry 2010; 197:272-277.
29. Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002; 113:91-98.
30. Pence BW. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother 2009; 63:636-640.
31. Ironson G, O'Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med 2005; 67:1013-1021.
32. Tsai AC, Weiser SD, Petersen ML, Ragland K, Kushel MB, Bangsberg DR. A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. Arch Gen Psychiatry 2010; 67:1282-1290.
33. Peretti-Watel P, Spire B, Lert F, Obadia Y. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug Alcohol Depend 2006; 82:S71-S79.
34. Kashner TM. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 1998; 36:1324-1336.
35. Richardson LK, Egede LE, Mueller M. Effect of race/ethnicity and persistent recognition of depression on mortality in elderly men with type 2 diabetes and depression. Diabetes Care 2008; 31:880-881.
36. Sajatovic M, Blow F, Ignacio RV. Psychiatric comorbidity in older adults with bipolar disorder. Int J Geriatric Psychiatry 2006; 21:582-587.
37. Lee TA, Bartle B, Weiss KB. Impact of NSAIDS on mortality and the effect of preexisting coronary artery disease in US veterans. Am J Med 2007; 120:98.
38. Al-Aly Z, Pan H, Zeringue A, Xian H, McDonald JR, El-Achkar TM, et al. Tumor necrosis factor-a blockade, cardiovascular outcomes, and survival in rheumatoid arthritis. Transl Res 2011; 157:10-18.
39. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM. Rate of kidney function decline associates with mortality. J Am Soc Nephrol 2010; 21:1961-1969.
40. The SMART/INSIGHT and the D:A:D Study Groups. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS 2008; 22:F17-F24.
41. Friis-Moller N, Weber R, Reiss P, Thibaut R, Kirk O, Monforte AA, et al. Cardiovascular disease risk factors in HIV patients: association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17:1179-1193.